1-10 of 10
Daniel Stachel
Close
Sort by
Journal Articles

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Krzysztof Kalwak, MD, Peter Bader, MD PhD, Jan Styczynski, PhD, Bernd Gruhn, MD, Katharine Patrick, MD, Petr Sedlacek, MD, Daniel Stachel, MD, Karl-Walter Sykora, MD, Selim Corbacioglu, MD, Katarzyna Drabko, MD, Franca Fagioli, MD, Johann Greil, MD, Franco Locatelli, Ingo Müller, MD, Bernhard Kremens, MD PhD, Paul G. Schlegel, MD, Jolanta Gozdzik, MD PhD, Birgit Burkhardt, MD PhD, Monika Mielcarek-Siedziuk, MD, Ajay Vora, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3354.
https://doi.org/10.1182/blood-2018-99-110980
Published: 2018
Journal Articles

Nivolumab As Salvage Therapy in Pediatric Patients with Relapsed and Refractory Lymphomas

Nora Naumann-Bartsch, MD, Daniel Stachel, MD, Martin Chada, MD, Torsten Fritscher, MD, Oliver Rompel, MD, Florian Haller, MD, Arndt Hartmann, MD, Wilhelm Wößmann, MD, Markus Metzler, MD
Journal: Blood
Blood (2016) 128 (22): 5414.
https://doi.org/10.1182/blood.V128.22.5414.5414
Published: 2016
Journal Articles

Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome

Simon Völkl, Anne Rensing-Ehl, Andrea Allgäuer, Elisabeth Schreiner, Myriam Ricarda Lorenz, Jan Rohr, Christian Klemann, Ilka Fuchs, Volker Schuster, André O. von Bueren, Nora Naumann-Bartsch, Eleonora Gambineri, Kathrin Siepermann, Robin Kobbe, Michaela Nathrath, Peter D. Arkwright, Maurizio Miano, Klaus-Daniel Stachel, Markus Metzler, Klaus Schwarz, Anita N. Kremer, Carsten Speckmann, Stephan Ehl, Andreas Mackensen
Journal: Blood
Blood (2016) 128 (2): 227–238.
https://doi.org/10.1182/blood-2015-11-685024
Published: 2016
Includes: Supplemental data
Journal Articles

Hyperactive mTOR Pathway Promotes Lymphoproliferation and Abnormal Differentiation in Human Autoimmune Lymphoproliferative Syndrome

Simon Voelkl, PhD, Anne Rensing-Ehl, Andrea Allgaeuer, Elisabeth Schreiner, Myriam Ricarda Lorenz, Jan Rohr, Christian Klemann, Ilka Fuchs, Volker Schuster, Andre von Bueren, Eleonora Gambineri, Kathrin Siepermann, Robin Kobbe, Peter Arkwright, Daniel Stachel, MD, Markus Metzler, MD PhD, Klaus Schwarz, Anita Kremer, MD, Carsten Speckmann, MD, Stephan Ehl, MD, Andreas Mackensen, MD
Journal: Blood
Blood (2015) 126 (23): 1020.
https://doi.org/10.1182/blood.V126.23.1020.1020
Published: 2015
Journal Articles

Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Children with Malignant and Non-Malignant Diseases

Michael H. Albert, MD, Johanna Tischer, MD, Daniel Stachel, MD, Anna von Schirnding de Almeida, MD, Volker Wiebking, MD, Christoph Klein, MD PhD, Irene Schmid, MD
Journal: Blood
Blood (2014) 124 (21): 5842.
https://doi.org/10.1182/blood.V124.21.5842.5842
Published: 2014
Journal Articles

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Peter Bader, Hermann Kreyenberg, PhD, Arend von Stackelberg, Cornelia Eckert, PhD, Meisel Roland, MD, Pötschger Ulrike, MD, Daniel Stachel, MD, Martin Schrappe, MD, Andre Schrauder, MD, Ansgar Schulz, MD, Peter Lang, MD, Ingo Mueller, MD, Michael H. Albert, MD, Thomas Klingebiel, MD, Christina Peters, MD
Journal: Blood
Blood (2013) 122 (21): 1995.
https://doi.org/10.1182/blood.V122.21.1995.1995
Published: 2013
Journal Articles

NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation

Hermann Kreyenberg, Andrea Jarisch, Christina Bayer, Blanca Schuster, Andre Willasch, Brigitte Strahm, Bernhard Kremens, Bernd Gruhn, Andre Schrauder, Stefan Burdach, Monika Führer, Claudia Rossig, Hartmut Kabisch, Paul-Gerhard Schlegel, Daniel Stachel, James F. Beck, Christine Mauz-Koerholz, Tje Lin Chung, Ernst Holler, Thomas Klingebiel, Peter Bader
Journal: Blood
Blood (2011) 118 (4): 1181–1184.
https://doi.org/10.1182/blood-2011-05-356451
Published: 2011
Journal Articles

TBI Based Conditioning Regimen and Intra Osseous Application of PBSC to Overcome Graft Resistance In a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS)

Daniel Stachel, MD, Nora Naumann-Bartsch, MD, Patrick Morhart, MD, Markus Metzler, MD, Thorsten Langer, MD, Klaus Schwarz, Wolfgang Holter, MD
Journal: Blood
Blood (2010) 116 (21): 4696.
https://doi.org/10.1182/blood.V116.21.4696.4696
Published: 2010
Journal Articles

Clinical Phenotype and Long Term Outcome in a Large Cohort of X-Linked Thrombocytopenia (XLT)/Mild Wiskott-Aldrich-Syndrome Patients

Michael H Albert, MD, Tanja Bittner, Daniel Stachel, MD, Shigeaki Nonoyama, Lucia Notarangelo, Siobhan Burns, Isabelle Pellier, Gabriele Strauss, Tomohiro Morio, Kohsuke Imai, Teresa Espanol, Benjamin Gathmann, Manfred Hönig, Jeroen G Noordzij, Michaela Nathrath, Alfons Meindl, Uwe Wintergerst, Alain Fischer, Adrian Thrasher, MD, PhD, Bernd H Belohradsky, Hans D Ochs
Journal: Blood
Blood (2008) 112 (11): 90.
https://doi.org/10.1182/blood.V112.11.90.90
Published: 2008
Journal Articles

Control of Fulminant Juvenile Myelomonocytic Leukemia (JMML) Relapse and Gut GvHD III° with Purinethol Early after Unrelated Donor BMT.

Daniel Stachel, M.D., Chara Gravou-Apostolatou, M.D., Michaela Kuhlen, M.D., Alfred Leipold, M.D., Peter Bader, M.D., Jorn Beck, M.D., Wolfgang Holter, M.D.
Journal: Blood
Blood (2004) 104 (11): 5089.
https://doi.org/10.1182/blood.V104.11.5089.5089
Published: 2004